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Seon-Ha Kim1, Seon-Ok Kim2, Sang-il Lee3 and Min-Woo Jo3*Abstract
Background: There is no research on mapping algorithms between EQ-5D and SF-36 in Korea. The aim of this
study was to derive a predictive model for converting the SF-36 health profile to the EQ-5D index using data from
several studies.
Methods: Individual data (n = 2211) were collected from three different studies and separated into derivation
(n = 1660) and internal validation sets (n = 551). Data from 123 colon cancer patients were analyzed for external
validation. The prediction models were analyzed using ordinary least-square (OLS) regression, two-part modeling,
and multinomial logistic modeling using eight scale scores; two summary scores and the interaction terms of SF-36
were used as independent variables. The EQ-5D index using the Korean value set and each dimension of the EQ-5D
were used as dependent variables. The mean absolute errors (MAE) and R2 values of the internal and external
validation dataset were used to evaluate model performance.
Results: Our findings show that the three different scoring algorithms demonstrate similar performances in terms
of MAE and R2. After considering familiarity and parsimony, the OLS model (including Physical Function, Bodily Pain,
Social Function, Role Emotional, and Mental Health) was found to be optimal as the final algorithm for use in this
study. The MAEs of the OLS models demonstrated consistent results in both the derivation (0.087–0.109) and
external validation sets (0.082–0.097).
Conclusion: This study provides mapping algorithms for estimating the EQ-5D index from the SF-36 profile using
individual data and confirms that these algorithms demonstrate high explanatory power and low prediction errors.
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Quality-adjusted-life year (QALY) is a single measure
that combines reduced morbidity (quality gains) and re-
duced mortality (quantity gains) [1]. Cost-utility analysis
in economic appraisal was developed to compare the
costs of a healthcare program and its beneficial impacts
on both length and quality of life [2]. Calculating QALYs
requires quality weights for each health state. Several
multi-attribute utility instruments and quality weight
tariffs are available: EuroQol-5 dimension (EQ-5D) [3],
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unless otherwise stated.Well-being Scale [6], and short form (SF)-6D [7]. Many
countries have derived country-specific utility weights,
and there is some evidence that the value sets between
countries are substantially different [8]. Therefore, map-
ping algorithms developed in other countries might be
inappropriate for Korean-specific decision making. Con-
verting algorithms from generic Health-related Quality
of Life (HRQOL) measures to preference-based mea-
sures is an increasingly common solution when health
utility values are unavailable for cost-utility analysis.
EQ-5D utility weights are already relatively common in
South Korea [9,10]. SF-36 is one of the most popular
generic instruments for measuring HRQOL, and SF-36
descriptive data are often available. Psychometric. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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has been demonstrated [11,12]. SF-6D was developed as
a preference-based measure that uses either SF-36 or
SF-12 [7,13]; however, no algorithm exists in Korea for
converting SF-36 to SF-6D. Therefore, Korean-specific
mapping algorithms for converting SF-36 to EQ-5D
utility index are needed.
Several algorithms for converting the SF family of instru-
ments to EQ-5D have been introduced [14-16], including
ordinary least-square (OLS) regression, multinomial logis-
tic (MNL) regression, and censored least absolute devia-
tion (CLAD) regression. The independent variables, two
summary scores, eight domain scores, and item responses
included on the SF family instrument are used in these
algorithms. There is no standard mapping technique that
can translate SF-36 to the EQ-5D utility index. OLS
regression is one of most frequently used mapping ap-
proaches because of its applicability and interpretability.
The two-part approach consists of logistic and least-
square regressions that model specific features of the
EQ-5D index, such as ceiling effect and other data in-
cluded in the EQ-5D index [17]. A variety of mapping
method to convert SF data to EQ-5D demonstrated incon-
sistent results in previous studies. Chuang & Kind sug-
gested that OLS regression is more accurately estimates
group mean than MNL, CLAD, and two-part modeling
[14]. Rowen et al. reported that random-effects Generalized
Least Squares demonstrates more accurate predictions than
Tobit or CLAD [18]. On the other hand, Sullivan &
Ghushchyan reported that the CLAD demonstrates the
lowest mean predictive error, followed by OLS and Tobit
[19]. Le & Doctor reported that Bayesian networks con-
sistently outperform other mapping models, including
MNL, OLS, and CLAD [20].
This study explores mapping algorithms for converting
SF-36 to the Korean EQ-5D index using three different
techniques: OLS regression, MNL regression, and two-
part modeling.Methods
Datasets
Individual-level data (n = 2211) were collected from three
published studies and randomly divided into derivation
(n = 1660) and internal validation sets (n = 551). These
three studies included patients from the general popula-
tion [21], type 2 diabetic patients visiting outpatient clinics
at three university hospitals [22], and stroke patients in
a single community [23]. Survey data that measured
HRQOL in colon cancer patients (n = 123) was also used
for external validation [24]. Study on general population,
type 2 diabetic patients, stroke patients and colon cancer
patients were conducted in 2011, 2007, 2008 and 2010, re-
spectively. Further details are elsewhere [21-24].Instruments
All surveys included both the EQ-5D and SF-36 question-
naires. EQ-5D is a generic preference-based measure that
describes health status according to five dimensions:
mobility, self-care, usual activities, pain discomfort, and
anxiety/depression. Each dimension is scored accordingly:
no problem, some or moderate problems, or extreme
problems [25]. The EQ-5D utility index was calculated
using the valuation set from the Korean population [10].
Therefore, possible EQ-5D scores range from −0.171 to
1.0, with 1.0 denoting “full health” (11111 state) and 0.0
denoting “death”.
SF-36 is a generic health measure that consists of 36
items with 3–6 levels. The SF-36 health profiles measure
eight health domain scores (physical functioning [PF],
role-physical [RP], role-emotional [RE], bodily pain [BP],
general health [GH], vitality [VT], mental health [MH],
and social functioning [SF]) and two summary scores
(physical component summary [PCS] and mental com-
ponent summary [MCS]) [26]. Each raw domain scores
can be converted to a 0–100 scale, where a higher score
indicates a higher health status.Analysis
Three approaches—OLS regression, two-part modeling,
and MNL modeling—were used to develop a mapping
algorithm for converting SF-36 to EQ-5D.OLS regression
OLS chooses regression coefficients in order to minimize
the sum of the squares of the errors. A recent mapping re-
view reported that the most common mapping method
was OLS [27]. However, The OLS model does not restrict
the range of values and therefore may lead to implausible
predicted values outside of the existing range of the EQ-
5D values [28]. We used OLS regression with the sand-
wich variance estimator in order to account for the clus-
tering effects of communities and hospitals.Two-part modeling
Two-part modeling is recommended because of the spe-
cific features of the EQ-5D index described above [29].
This model divides the study population accordingly:
people who report a full health state on EQ-5D (i.e.,
11111), and people who had > 1 problem on any of the
five dimensions on EQ-5D. The first part of the model
consists of logistic regression, which is used to deter-
mine the probability of achieving the maximum EQ-5D
index score of 1.0. The second part is least-square re-
gression with robust variance estimation of the EQ-5D
scores, which is performed on the subset of patients
whose EQ-5D score is not equal to 1.0 [17].
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The MNL model estimates a particular level for each
EQ-5D dimension rather than using the EQ-5D index
score. We used the MNL model for each EQ-5D dimen-
sion to derive the probability that the dimension was at
level 1, 2 or 3, and then Monte Carlo simulation was
used to generate random number (ui) between 0 and 1
[30]. We performed multiple Monte Carlo simulations
using derivation set, but the results are similar, and so
we generated random variables by a single simulation.
Here, P1(Xj), P2(Xj), and P3(Xj) indicate the predicted
probabilities of MNL regression for response levels 1, 2,
and 3, respectively, where Xj represents the each EQ-5D
domain. A response level for each of the EQ-5D do-
mains was assigned as follows using P1(Xj), P3(Xj) and ui
generated from simulation [20]:
Predicted EQ−5D response level ¼
1 if ui≤P1 Xj
 
2 if P1 Xð Þ < ui≤ 1−P3 Xj
  
3 if ui > 1−P3 Xj
  
Using estimated responses across all five dimensions, a
health state and index score can be determined accor-
ding to the Korean EQ-5D value set [10].
Model specification
We assessed the two approaches for assessing indepen-
dent variables that are described in previously reported
studies [14,15,18]. One model used eight raw scale scores
from SF-36, and the other used two summary measures
(PCS and MCS) with or without the square term and
demographic variables (e.g., sex, age, education level,
marital status). The dependent variable was the EQ-5D
utility score. Models for use in OLS regression were
selected using the backward elimination method, and
p < 0.05 was considered statistically significant. OLS
models were estimated using the following: (1) all eight
scales; (2) backward elimination of all eight scales; (3)
backward elimination of all eight scales and their squared
terms; (4) backward elimination of all eight scales, their
squared terms, and demographic factors; (5) two summary
measures; and (6) two summary measures, their squared
terms, and their interaction terms. The independent
variables in models 1, 2, 3, and 6 were used in MNL and
two-part modeling.
To compare models, we considered goodness-of-fit,
applicability, and parsimony. Goodness-of-fit represents
how well the model explains the observed data. We ex-
amined these models using residual diagnostic plots.
Mean absolute error (MAE)—the average of the absolute
differences between observed and predicted values—
and root mean squared error (RMSE) were considered
an important indicator during model selection. Small
MAE indicates a better model. Proportions of estimation
with absolute error > 0.05 and absolute error > 0.1 werealso assessed. R2 on OLS regression, pseudo R2 on
MNL, the mean of the estimated EQ-5D index score,
and the ranges of both the derivation and validation sets
were computed. Finally, practical applicability and model
simplicity were considered if the models demonstrated
similar MAE and R2 values.
All statistical analyses were conducted using SAS
(ver. 9.1; SAS institute Inc., Cary, NC).
Results
Demographic characteristics
The total number of individuals used in the derivation,
internal, and external validation sets were 1660, 551, and
123, respectively. The demographic characteristics and
health status for these three sets are presented in Table 1.
The average age of the derivation set was 56.9 years
(SD = 15.0), 44.8% were female, and the average EQ-5D
index score was 0.816 (SD = 0.266). There are no sig-
nificantly different variables between the derivation and
internal validation sets, whereas significant differences in
the EQ-5D index, PF, GH, VT, MH, and PCS scores bet-
ween the derivation and external validation sets shows
that the respondents in the external validation set
tended to be healthier than those in derivation set.
OLS regression performance
The results of the OLS regression analysis are shown in
Table 2. In the derivation set, R2 values ranged between
0.680–0.750. All OLS models predicted the average EQ-5D
index, however the upper limits of estimation for all OLS
models (except model 6) exceeded the upper limit of the
EQ-5D index (i.e., 1). The coefficients of RP, GH, and VT
in model 1 were not statistically significant. Among all
models, models 3 and 4 demonstrated the lowest MAE
values (0.087) and proportions of estimation with absolute
error >0.05 or absolute error > 0.1 were lower than the
other OLS models. Similar findings were observed in the
internal and external validation sets. Demographic factors
were not statistically significant (except age).
Two-part modeling performance
The performance of the two-part model is described
Table 3. Models 7, 8, 9, and 10 used the same indepen-
dent variables as models 1, 2, 3, and 6, respectively. The
predicted mean EQ-5D indexes of models 7, 8, 9 and 10
were 0.829, 0.829, 0.829, and 0.828 respectively, which
are slightly higher than the actual EQ-5D index of 0.817.
According to the two-part model, the upper and lower
boundaries of the predicted EQ-5D are lower than the
OLS models. Of the included two-part models, model 9
demonstrated the lowest MAE value of 0.081 in the
derivation set; on the other hand, the external validation
set demonstrated the MAE value of 0.086.
Table 1 Demographic characteristic and health states of the included patients
Variables Derivation set Internal
validation set
External
validation setTotal General population Diabetes mellitus Stroke
n 1660 448 770 442 551 123
Age (y), mean (SD) 56.9 (15.0) 44.5 (15.5) 57.6 (11.9) 68.3 (8.2) 58.3 (14.5) 57.1 (10.0)
Female (%) 44.8 50.2 44.4 39.8 44.7 36.6
Education (%)
Elementary 30.9 8.5 25.1 63.6 33.2 -
Middle school 13.5 9.2 16.4 12.9 11.3 -
High school 33.4 47.5 33.2 19.5 34.1 -
College or higher 22.2 34.8 25.3 4.1 21.4 -
Marital status, married (%) 72.5 70.3 77.3 70.3 75.8 -
EQ-5D index, mean (SD) 0.816 (0.266) 0.945 (0.091) 0.914 (0.124) 0.513 (0.325) 0.831 (0.236) 0.871 (0.113)
EQ-5D profile, 11111(%) 43.2 65.4 53.1 3.4 43.2 30.1
EQ-5D profile, 33333(%) 1.7 0 0.1 6.1 0.9 0
SF-domain scores, mean (SD)
PF 66.1 (34.8) 86.6 (21.8) 77.8 (23.8) 25.0 (27.0) 65.9 (34.2) 72.1 (22.6)
RP 68.7 (35.8) 89.0 (20.4) 79.2 (27.8) 29.8 (30.6) 69.3 (34.8) 65.4 (29.3)
BP 72.3 (28.9) 84.4 (22.1) 77.6 (26.9) 50.8 (27.1) 71.5 (29.2) 76.4 (24.5)
GH 49.1 (23.9) 66.3 (19.7) 50.5 (20.5) 29.2 (18.2) 49.2 (23.7) 56.6 (20.0)
VT 40.7 (21.4) 54.1 (16.2) 42.8 (20.1) 23.3 (16.3) 39.7 (21.1) 47.4 (18.7)
SF 73.4 (32.0) 89.0 (18.5) 84.4 (22.5) 38.4 (30.6) 73.3 (31.2) 75.0 (24.6)
RE 73.8 (34.0) 89.8 (18.9) 83.8 (25.1) 40.2 (36.5) 74.8 (32.5) 71.7 (29.7)
MH 66.0 (24.7) 76.9 (17.7) 72.1 (21.4) 44.5 (44.5) 66.2 (24.6) 70.1 (19.7)
SF summary score, mean (SD)
PCS 44.7 (11.7) 52.2 (8.0) 47.4 (9.2) 32.3 (9.1) 44.5 (11.5) 46.5 (8.0)
MCS 43.9 (13.1) 49.9 (8.3) 47.3 (10.8) 31.9 (13.0) 44.0 (12.8) 44.9 (11.0)
PF, physical functioning; RP, role- physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role -emotional; MH, mental health;
PCS, physical component summary; MCS, mental component summary.
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The MNL performances of the models are shown Table 4.
Models 11, 12, 13, and 14 used the same independent
variables as models 1, 2, 3, and 6, respectively. The pseudo
R2 value of model 13 ranged between 0.455–0.615, which
is slightly higher than models 11, 12 and 14. Proportions
of estimation with absolute error > 0.05 or > 0.1 for MNL
modeling of the derivation set were considerably lower
that the OLS and two-part models, while the MAEs of the
MNL models except model 12 were similar to the OLS
and two-part models. Proportions of estimation > 0.05 in
absolute error in MNL model in external validation de-
creased at around 45%, and it was lower than the OLS
and two-part models.
We displayed scatter plot of predicted values versus the
actual EQ-5D index in external validation sample in OLS
(Model 3), two-part model (Model 9) and MNL model
(Model 13) using same explanatory variables (Figure 1)
We also compared mean predicted value between cancer
patients with and without active chemotherapy in 3different models (Table 5). Mean predicted value in OLS
and MNL were closer to actual mean value than two-part
model.
Discussion
SF-36 is one of the most frequently used HRQOL in-
struments, and the EQ-5D is a unique instrument with
national tariffs that were developed for use in Korea. In
this study, eight domain scores or two SF-36 summary
measures were mapped onto EQ-5D utility scores using
diverse model specifications. Our findings show that the
three different scoring algorithms demonstrate similar
performances in terms of MAE and R2 values. Consi-
dering familiarity and predictability, the OLS model
(including PF, BP, SF, RE, MH, GH, PF squared, SF
squared and RE squared) could be recommended as the
final algorithm in this study.
Our findings are comparable with previously reported
evidence. The MAEs for our OLS models demonstrate
consistent results for both the derivation (0.087–0.109)
Table 2 Ordinary least-square regression modeling performed using main effects with or without significant
demographic and squared terms
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
β SE β SE β SE β SE β SE β SE
Derivation set
Intercept 0.0161 0.1019 0.0168 0.0999 −0.7629 0.1066 −0.6947 0.0861 0.9277 0.0040 0.9582 0.0059
PF 0.0179 0.0030 0.0180 0.0027 0.0696 0.0091 0.0720 0.0092
RP 0.0010 0.0014
BP 0.0051 0.0013 0.0050 0.0009 0.0114 0.0007 0.0115 0.0007
GH 0.0003 0.0004 0.0029 0.0011 0.0024 0.0010
VT −0.0018 0.0021
SF 0.0162 0.0024 0.0166 0.0022 0.0656 0.0086 0.0644 0.0082
RE 0.0102 0.0040 0.0107 0.0036 0.0432 0.0054 0.0418 0.0055
MH 0.0050 0.0005 0.0043 0.0013 0.0058 0.0011 0.0058 0.0011
PF squared −0.0013 0.0002 −0.0014 0.0002
SF squared −0.0042 0.0005 −0.0041 0.0005
RE squared −0.0018 0.0002 −0.0017 0.0002
Age −0.0011 0.0003
PCS 0.1227 0.0182 0.0509 0.0046
MCS 0.0769 0.0128 0.0196 0.0029
PCS × PCS −0.0265 0.0037
MCS ×MCS −0.0113 0.0015
PCS ×MCS −0.0334 0.0034
R2 0.6807 0.6804 0.7476 0.7498 0.6366 0.7093
MAE 0.101 0.101 0.087 0.087 0.109 0.094
AE > 0.05 (%) 53.1 52.7 49.6 50.0 62.8 50.4
AE > 0.1 (%) 33.9 34.3 28.0 28.4 36.8 29.3
RMSE 0.150 0.150 0.134 0.133 0.160 0.143
EQ-5D index Actual Predict Predict Predict Predict Predict Predict
Mean (SD) 0.816 (0.266) 0.816 (0.220) 0.816 (0.220) 0.816 (0.230) 0.816 (0.230) 0.816 (0.212) 0.816 (0.224)
Min/max −0.171/1 0.291/1.057 0.293/1.049 0.099/1.020 0.091/1.037 0.285/1.111 −0.002/0.997
Internal validations set
MAE 0.103 0.103 0.091 0.088 0.108 0.096
AE > 0.05 (%) 55.5 55.7 47.9 51.2 61.5 51.4
AE > 0.1 (%) 35.4 37.0 29.8 29.4 36.5 30.0
RMSE 0.147 0.147 0.132 0.131 0.155 0.144
EQ-5D index Actual Predict Predict Predict Predict Predict Predict
Mean (SD) 0.831 (0.236) 0.809 (0.217) 0.809 (0.217) 0.824 (0.217) 0.812 (0.228) 0.819 (0.201) 0.822 (0.208)
Min/max −0.171/1 0.294/1.059 0.293/1.049 0.143/1.015 0.113/1.040 0.343/1.104 0.131/0.993
External validation set
MAE 0.092 0.082 0.085 0.086 0.097 0.083
AE > 0.05 (%) 61.0 61.0 56.1 61.0 66.7 56.1
AE > 0.1 (%) 35.8 35.0 30.9 33.3 41.5 26.8
RMSE 0.123 0.123 0.114 0.115 0.126 0.115
Kim et al. Health and Quality of Life Outcomes 2014, 12:145 Page 5 of 10
http://www.hqlo.com/content/12/1/145
Table 2 Ordinary least-square regression modeling performed using main effects with or without significant
demographic and squared terms (Continued)
EQ-5D index Actual Predict Predict Predict Predict Predict Predict
Mean (SD) 0.871 (0.113) 0.840 (0.149) 0.842 (0.150) 0.894 (0.125) 0.893 (0.121) 0.846 (0.156) 0.875 (0.129)
Min/max 0.537/1 0.432/1.045 0.430/1.049 0.418/1.032 0.416/1.023 0.435/1.111 0.355/0.984
PF, physical functioning; RP, role- physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role -emotional; MH, mental health;
PCS, physical component summary; MCS, mental component summary; MAE, mean absolute error; AE, absolute error; RMSE, root mean squared error.
Bold values are not significant (p > 0.05).
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Ara & Brazier’s study, which were determined using a
similar methodology, was approximately 0.13 [15]. The
MAE of the OLS model was 0.0746 according to Sullivan
et al., who mapped the two SF-12 summary measures,
squared terms, and demographic variables onto the
US-based EQ-5D index [19]. The OLS models in our
study determined R2 between 64% (Model 5) and 75%
(Model 3 & 4) for the EQ-5D index. The reported variance
in Ara & Brazier’s study, which used similar independentTable 3 Two-part modeling (logistic + ordinary least-square re
Model 7a Model 8b
Derivation set
MAE 0.089 0.089
AE > 0.05 (%) 50.3 49.7
AE > 0.1 (%) 31.9 31.9
RMSE 0.298 0.299
Predicted EQ-5D index
Mean (SD) 0.829 (0.233) 0.829 (
Min/max 0.193 1.078 0.198 1
Internal validation set
MAE 0.090 0.089
AE > 0.05 (%) 50.8 52.3
AE > 0.1 (%) 34.3 47.7
RMSE 0.301 0.303
Predicted EQ-5D index
Mean (SD) 0.823 (0.231) 0.829 (
Min/max 0.222 1.082 0.198 1
External validation set
MAE 0.091 0.091
AE > 0.05 (%) 57.7 59.4
AE > 0.1 (%) 38.2 39.0
RMSE 0.302 0.302
Predicted EQ-5D index
Mean (SD) 0.885 (0.113) 0.881 (
Min/max 0.377 1.034 0.537 1
MAE, mean absolute error; AE, absolute error; RMSE, root mean squared error.
aIndependent variables: PF, RP, BP, GH, VT, SF, RE, MH.
bIndependent variables: PF, BP, SF, RE, MH.
cIndependent variables: PF, BP, GH, SF, RE, MH, PF squared, SF squared, RE squared
dIndependent variables: PCS, MCS, PCS × PCS, MCS ×MCS, PCS ×MCS.variables as our study, varied between 56–59% [15]. The
explanatory power of OLS regression when mapping the
two SF-12 summary measures onto the UK-based EQ-5D
index was 62.9%, and 65.6% when mapping all 12 items of
SF-12 onto the UK-based EQ-5D index [14]. RP, VT, and
GH domain scores were the non-significant when ap-
plying the domain scores in OLS model. This pattern is
very similar to Ara & Brazier’s findings [15].
Two-part modeling demonstrated worse predictive
power in aspects of RMSE than OLS regression and modelgression): predicting EQ-5D index scores from SF-36





0.233) 0.829 (0.239) 0.828 (0.234)





0.233) 0.825 (0.237) 0.826 (0.229)





0.154) 0.908 (0.125) 0.890 (0.129)
.000 0.421 1.000 0.353 1.000
.
Table 4 Multinomial logistic modeling: predicting EQ-5D index scores from SF-36
Model 11a Model 12b Model 13c Model 14d
Derivation set
R2 0.452–0.611 0.445–0.607 0.455–0.615 0.421–0.576
MAE 0.088 0.121 0.084 0.099
AE > 0.05 (%) 32.8 49.8 32.2 34.3
AE > 0.1 (%) 25.0 45.5 23.7 26.0
RMSE 0.297 0.347 0.290 0.315
Predicted EQ-5D index
Mean (SD) 0.826 (0.279) 0.731 0.310 0.826 (0.279) 0.829 (0.185)
Min/max −0.171 /1.000 −0.171 1.000 −0.171 /1.000 −0.171 /1.000
Internal validation set
MAE 0.097 0.119 0.092 0.101
AE > 0.05(%) 35.9 48.5 37.2 35.9
AE > 0.1(%) 28.7 43.2 28.9 28.1
RMSE 0.312 0.344 0.304 0.315
Predicted EQ-5D index
Mean (SD) 0.825 (0.288) 0.732 0.313 0.821 (0.292) 0.828 (0.292)
Min/max −0.171 /1.000 −0.171 1.000 −0.171 /1.000 −0.171 /1.000
External validation set
MAE 0.085 0.125 0.075 0.084
AE > 0.05 (%) 47.2 60.2 45.5 44.7
AE > 0.1 (%) 26.0 52.0 26.0 26.8
RMSE 0.292 0.354 0.273 0.290
Predicted EQ-5D index
Mean (SD) 0.883 (0.164) 0.753 0.204 0.892 (0.131) 0.877 (0.170)
Min/max −0.171 /1.000 −0.171 1.000 0.151 /1.000 −0.171 /1.000
MAE, mean absolute error; AE, absolute error ; RMSE, root mean squared error.
aIndependent variables: PF, RP, BP, GH, VT, SF, RE, MH.
bIndependent variables: PF, BP, SF, RE, MH.
cIndependent variables: PF, BP, GH, SF, RE, MH, PF squared, SF squared, RE squared.
dIndependent variables: PCS, MCS, PCS × PCS, MCS ×MCS, PCS ×MCS.
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independent variables among those sets considered in
comparison with OLS regression. The MAE values of the
MNL models ranged between 0.084–0.099 for the de-
rivation set and 0.075–0.101 for the validation set. These
values are similar or slightly lower than the OLS regression
values. Gray et al. reported an MAE value of 0.11 for the
derivation set and 0.12 for the validation set when map-
ping all SF-12 questions to EQ-5D [30]. The range of the
actual EQ-5D index was −0.171–1.0. The MNL model
covered the entire possible EQ-5D range of the derivation
set, however OLS regression covered 61–85% and the
two-part model covered 69–93%.
A review of eight longitudinal studies reported a mean
minimal important difference (MID) value of 0.074
(range = −0.011–0.140) for the EQ-5D index [31]. How-
ever, we cautiously used the mapping algorithm used in
this study after considering that the MAE magnitude ofthis study was slightly higher than the conventional MID
value of the EQ-5D index, and there was substantial
proportion of estimation > 0.1 in terms of absolute error
especially when applying the algorithms to datasets that
are likely to have very low utility values.
Our current study has several strengths. First, we used
patients with a range of HRQOL severity, from stroke
patients to the general population; thus, our mapping
algorithm could be applied to assess patients with va-
rious conditions. We ran OLS model in each different
patient groups. Three (PF, BP, MH) out of five coeffi-
cients in OLS model showed equal statistical significant
and sign in three different populations, although inter-
action of only PF and RE between groups showed statis-
tically significant in the derivation set.
Second, our model was validated using both internal
and external validation sets. Third, our data-collection
methods were consistent, although data were obtained
Figure 1 Scatter plot of predicted values versus the actual EQ-5D index in the external validation sample; (a) ordinary least square
regression (model 3) (b) two-part model (model 9) (c) multinominal logistic model (model 13).
Table 5 Mean actual value and predicted value between external validation samples with and without current
chemotherapy in 3 different models
Actual value Predicted value
OLSa Two part modela MNLa
Current chemotherapy (N = 95) 0.855 0.873 0.887 0.871
No current chemotherapy(N = 28) 0.915 0.951 0.965 0.949
aIndependent variables: PF, BP, GH, SF, RE, MH, PF squared, SF squared, RE squared.
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team was involved in multiple studies. However, our
present study also had several limitations. First, our
external validation set tended to be healthier than the
derivation set. There is some evidence that the MAE
value of patients in poor health is higher than patients in
good health when converting other HRQOL instruments
to the EQ-5D index. Thus, further external validation of
patients with severe conditions would be useful for veri-
fying these findings. Second, this study examined only
three mapping techniques. We also did not consider inter-
action between EQ-5D dimensions assuming indepen-
dency in the MNL model, and further evaluation of the
model is needed considering interaction between dimen-
sions. There are other methodologies, such as CLAD and
probabilistic mapping techniques using Bayesian networks
[20], that could also be used.
Mapping between HRQOL measures onto EQ-5D
utilities should be considered at best second-best method
directly collected EQ-5D values [28]. Uncertainties in
health utilities derived from mapping algorithm tend to be
underestimated. Chan et al. recently reported correction
method for the underestimation of variance of mapping
algorithm–derived health utility [32].
Conclusion
Predictability of OLS, MNL, and Two-part model are simi-
lar in mapping between SF-36 and EQ-5D health utility
scores. OLS methods seems to be appropriate in aspects of
model predictability and convenient application compared
with two part model and MNL in our study yet the
method may not always accurately predict the EQ-5D for
poor health states. Currently, there is no Korean valuation
set for SF-6D. Although there are some limitations to
these algorithms, mapping from SF-36 scores and EQ-5D
index could be used in economic evaluation as well as
in clinical research until social tariff of SF-6D will be
developed.
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